These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11759884)

  • 21. Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts.
    Brauner R; Laks H; Drinkwater DC; Chaudhuri G; Shvarts O; Drake T; Bhuta S; Mishaly D; Fishbein I; Golomb G
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):53-63. PubMed ID: 9240294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of intimal hyperplasia by single-dose pre-insertion external radiation in canine-vein interposition grafts.
    Ulus AT; Tütün U; Zorlu F; Can C; Apaydin N; Karacagil S; Katircioğlu SF; Bayazit M
    Eur J Vasc Endovasc Surg; 2000 May; 19(5):456-60. PubMed ID: 10828224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of cilostazol on nerve conduction velocity and blood flow: acute and chronic cauda equina compression in a canine model.
    Sekiguchi M; Aoki Y; Konno S; Kikuchi S
    Spine (Phila Pa 1976); 2008 Nov; 33(24):2605-11. PubMed ID: 19011541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
    Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
    J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
    Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
    J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation.
    Ota H; Eto M; Ako J; Ogawa S; Iijima K; Akishita M; Ouchi Y
    J Am Coll Cardiol; 2009 Jun; 53(24):2298-305. PubMed ID: 19520256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
    Davies MG; Huynh TT; Hagen PO
    J Surg Res; 2000 Jul; 92(1):103-7. PubMed ID: 10864489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ezetimibe reduces intimal hyperplasia in rabbit jugular vein graft.
    Maekawa T; Komori K; Morisaki K; Itoh T
    J Vasc Surg; 2012 Dec; 56(6):1689-97. PubMed ID: 22857809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture.
    Takahashi S; Oida K; Fujiwara R; Maeda H; Hayashi S; Takai H; Tamai T; Nakai T; Miyabo S
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):900-6. PubMed ID: 1282592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease.
    Ehsan A; Mann MJ; Dell'Acqua G; Tamura K; Braun-Dullaeus R; Dzau VJ
    Circulation; 2002 Apr; 105(14):1686-92. PubMed ID: 11940548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts.
    Fulton GJ; Davies MG; Barber L; Gray JL; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):279-89. PubMed ID: 9610339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model.
    Yamaguchi-Okada M; Nishizawa S; Mizutani A; Namba H
    Cerebrovasc Dis; 2009; 28(2):135-42. PubMed ID: 19506373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All-trans-retinoic acid decreases cell proliferation and increases apoptosis in an animal model of vein bypass grafting.
    Leville CD; Osipov VO; Jean-Claude JM; Seabrook GR; Towne JB; Cambria RA
    Surgery; 2000 Aug; 128(2):178-84. PubMed ID: 10922989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dipeptidyl peptidase 4 inhibitor reduces intimal hyperplasia in rabbit autologous jugular vein graft under poor distal runoff.
    Koyama A; Komori K; Otsuka R; Kajikuri J; Itoh T
    J Vasc Surg; 2016 May; 63(5):1360-70. PubMed ID: 25656593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on pulmonary vascular tone].
    Shigemori K; Ishizaki T; Takahashi H; Sasaki F; Ameshima S; Ohnishi T; Sakai T; Nakai T; Miyabo S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Aug; 31(8):936-41. PubMed ID: 8230891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cilostazol on the production of platelet-derived growth factor in cultured human vascular endothelial cells.
    Mizutani M; Okuda Y; Yamashita K
    Biochem Mol Med; 1996 Apr; 57(2):156-8. PubMed ID: 8733895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor.
    Morishita R; Higaki J; Hayashi SI; Yo Y; Aoki M; Nakamura S; Moriguchi A; Matsushita H; Matsumoto K; Nakamura T; Ogihara T
    Diabetologia; 1997 Sep; 40(9):1053-61. PubMed ID: 9300242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locally applied cilostazol suppresses neointimal hyperplasia by inhibiting tenascin-C synthesis and smooth muscle cell proliferation in free artery grafts.
    Fujinaga K; Onoda K; Yamamoto K; Imanaka-Yoshida K; Takao M; Shimono T; Shimpo H; Yoshida T; Yada I
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):357-63. PubMed ID: 15354092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipo-prostaglandin E1 is absorbed by vascular smooth muscle cells and may enhance re-endothelialization of vein grafts.
    Akasaka N; Yamazaki K; Ishikawa M; Koya A; Hirasawa M; Inaba M; Goh K; Sasajima T
    J Cardiovasc Surg (Torino); 2002 Dec; 43(6):869-75. PubMed ID: 12483182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.